Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
History
Sports
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/c3/3e/fc/c33efcc2-426a-8ca0-5d5b-0d10f7b86c3d/mza_13682132506709836028.jpg/600x600bb.jpg
The TBPod
Actnet
44 episodes
5 months ago
Associate Professor Nicolas Alan Menzies, from the School of Global Health and Population at the Harvard T.H. Chan School of Public Health in Boston, Massachusetts, joins Dr Andrew Burke to discuss his research on the contribution of post-TB sequelae to life-years and quality-adjusted life-years lost due to TB disease in the United States. Drawing on data from both U.S. and Brazilian cohorts, he explores how a significant portion of TB’s health burden, including elevated mortality and reduced...
Show more...
Education
News,
Health & Fitness,
Medicine
RSS
All content for The TBPod is the property of Actnet and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Associate Professor Nicolas Alan Menzies, from the School of Global Health and Population at the Harvard T.H. Chan School of Public Health in Boston, Massachusetts, joins Dr Andrew Burke to discuss his research on the contribution of post-TB sequelae to life-years and quality-adjusted life-years lost due to TB disease in the United States. Drawing on data from both U.S. and Brazilian cohorts, he explores how a significant portion of TB’s health burden, including elevated mortality and reduced...
Show more...
Education
News,
Health & Fitness,
Medicine
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/c3/3e/fc/c33efcc2-426a-8ca0-5d5b-0d10f7b86c3d/mza_13682132506709836028.jpg/600x600bb.jpg
Tuberculosis Diagnostics & Emerging Technologies with Dr Morten Ruhwald
The TBPod
24 minutes
1 year ago
Tuberculosis Diagnostics & Emerging Technologies with Dr Morten Ruhwald
Today we delve into the world of TB diagnostics and the future of leveraged TB technologies with Dr Morten Ruhwald. Dr Ruhwald is a the head of the TB programme over at FIND, an institution dedicated to accelerating equitable access to reliable diagnosis around the world. Dr Ruhwald elaborates on the current state of TB diagnostics, new clinical strategies, usability factors, and future TB perspectives.https://www.finddx.org/what-we-do/programmes/tuberculosis/https://www.actnet.org.au/
The TBPod
Associate Professor Nicolas Alan Menzies, from the School of Global Health and Population at the Harvard T.H. Chan School of Public Health in Boston, Massachusetts, joins Dr Andrew Burke to discuss his research on the contribution of post-TB sequelae to life-years and quality-adjusted life-years lost due to TB disease in the United States. Drawing on data from both U.S. and Brazilian cohorts, he explores how a significant portion of TB’s health burden, including elevated mortality and reduced...